Dr Arun Dhandayudham Joint CEO and Medical Director WDP Feb Pharmacological Management of Opiate and Benzo Dependence in older people

Size: px
Start display at page:

Download "Dr Arun Dhandayudham Joint CEO and Medical Director WDP Feb Pharmacological Management of Opiate and Benzo Dependence in older people"

Transcription

1 Dr Arun Dhandayudham Joint CEO and Medical Director WDP Feb 2018 Pharmacological Management of Opiate and Benzo Dependence in older people

2 Epidemiology Who is an older person NDTMS Data

3 Whats Happening in Substance Misuse?

4 Very Little Opiate Neurobiology!!!! Mu1 Analgesia and euphoria Mu2-Constipation and respiratory depression Kappa-Spinal Analgesia and Dysphoria Delta-unkown Opiates modulation and other drugs of abuse

5 A walk through the system ENTRY TRIAGE MEDICAL ASSESSMENT OST STABILISATION REDUCTION DETOX

6 MEDICAL ASSESSMENT 1 Current Substance Misuse Is there a dependency? On what

7 Medical Assessment 2 Past Drug and Alcohol Hx

8 Medical Assessment 3 Medical Hx

9 MEDICAL ASSESSMENT 4 Psychiatric History

10 MEDICAL ASSESSMENT 5 Social Situation

11 MEDICAL ASSESSMENT 6 Motivation Goals Insight Want Putting it all together!!!

12 OST OPTIONS 1 Methadone

13 OST Options 2 Buprenorphine

14 What happens in the treatment system Keyworking GPSC Contingency Management Supervised Consumption Prenoxad

15 Reductions and Detoxifications IP OP Lofexidine Syptomatics

16 Relapse Prevention and Aftercare

17 Some thoughts about Benzos

18 An Aspirational Practical Way of Enhancing Treatment Delivery What substance misuse services could Example do additionally 1 for physical health Entry into substance misuse services What substance misuse services could do for mental health Full physical screening: At start At least annually Physical examination to include: Blood pressure and pulse rate ECG Blood sugar level BBV testing COPD status Blood tests- U&E, FBC, GGT Pain assessment MMSE Oral health check Co-working and Co-location with: GP Surgeries Diabetic Clinics COPD Clinic Cardiology Gastroenterology Sexual Health Clinics Dentistry Substance misuse triage covering: Illicit drug use Alcohol use GP summary Past drug and alcohol history Current and past mental health Current and past physical health Social situation issues Regular Reviews To cover the above areas and work with other local services One to one and group work to cover: Substance misuse issues Substance specific groups Relapse prevention Healthy lifestyle Weight management Smoking Life skills Community reintegration Education and skills Exercise groups Sleep hygiene Coping skills Screen for: Anxiety Mood Previous psychiatric input Current psychiatric input Mental health needs Collaborate with: OPMH service to optimise treatment within SM services And co-work with OPMH for patients with more serious MH needs

19 What OPMH services could do with regards to physical health Entry into OPMH Services What OPMH services could do with regards to substance misuse Full physical screening: At start Annually Physical examination to include: Blood pressure and pulse rate ECG Blood sugar level BBV testing COPD status Blood tests- UDE, FBC, GG7, LF7 Pain assessment Oral health checks Co-working with: GP Surgeries Secondary hospital services Diabetic Clinics COPD Clinic Cardiology Gastroenterology Sexual Health Clinics Dentistry Initial Appointments covering: Reasons for referral Mental health symptomology Substance misuse Physical health Social situation needs Regular Reviews To cover the above areas and wok with other local services Verbally Screen for: Illicit drug use NPS Alcohol issues Benzodiazepine use AUDIT/CAGE screens BBV testing Breathalyse /UDS/Saliva Test Blood tests FBC, U&E, GGT, LFT Brief Advice Work and Collaboration To collaborate with SM services to optimise services for clients Collaborate with SM services for more complex patients To use SM service expertise in group work/contingency management Substance misuse Benzo groups Cannabis and stimulant use groups Coping skills Relapse preventions Healthy lifestyle Weight management Smoking Community integration Education and skills Exercise groups Sleep hygiene Coping skills

HA Corporate Scholarship Program:

HA Corporate Scholarship Program: HA Corporate Scholarship Program: Substance Abuse Service in Psychiatry Ronnie Pao 02-10-10 The Maudsley Hospital Marina House Community Drug & Alcohol Team London Borough of Southwark Provides a Tier

More information

Managing drug misuse in pregnancy and beyond

Managing drug misuse in pregnancy and beyond Managing drug misuse in pregnancy and beyond Dr Emily Finch Clinical Director Addictions CAG, South London and Maudsley Foundation NHS Trust Rachel Evans, Adfam 1 / Aims of the session Update on management

More information

CommunIty detox. InformatIon LeafLet

CommunIty detox. InformatIon LeafLet residential CommunIty detox InformatIon LeafLet residential CommunIty detoxification programmes Peter McVerry Trust s Residential Community Detox currently offers the following Tier 4 residential programmes.

More information

The Challenge of offering a spectrum of alcohol services to homeless people. Pam Campbell

The Challenge of offering a spectrum of alcohol services to homeless people. Pam Campbell The Challenge of offering a spectrum of alcohol services to homeless people Pam Campbell Aims Brief overview of the work of the homeless healthcare team Assessment of alcohol use with patients, and frequently

More information

Guidance for naltrexone prescribing

Guidance for naltrexone prescribing Document level: Drug Alcohol (Trustwide) Code: DA7 Issue number: 2 Guidance for naltrexone prescribing Lead executive Authors details Type of document Target audience Document purpose Lead Clinical Director

More information

The science of the mind: investigating mental health Treating addiction

The science of the mind: investigating mental health Treating addiction The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with

More information

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification

More information

Managing long term opioids and hypnotics. Dr Ravneet Batra Consultant Liaison Psychiatrist Western General Hospital, Edinburgh

Managing long term opioids and hypnotics. Dr Ravneet Batra Consultant Liaison Psychiatrist Western General Hospital, Edinburgh Managing long term opioids and hypnotics Dr Ravneet Batra Consultant Liaison Psychiatrist Western General Hospital, Edinburgh Managing long term opioids and hypnotics Illicit opioid use Hypnotics - efficacy

More information

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE

More information

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification

More information

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE

LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE DR. SHILPA ADARKAR ASSOCIATE PROFESSOR DEPARTMENT OF PSYCHIATRY & DRUG DEADDICTION CENTRE OF EXCELLENCE SETH GSMC & KEMH LONG TERM OPTIONS FULL AGONIST PARTIAL

More information

The Woodlands Managing Alcohol To Support Recovery In Mental Health

The Woodlands Managing Alcohol To Support Recovery In Mental Health The Woodlands Managing Alcohol To Support Recovery In Mental Health Case Study: What Is Working Well From The Nottingham Perspective By Dr David Rhinds & Kevin Howard The Woodlands The Woodlands comprises

More information

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE INDICATION Naltrexone is a pure opiate antagonist licensed as an adjunctive prophylactic therapy in the maintenance

More information

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian 1. Introduction The provision of Substance Misuse (SM) services through

More information

Prescribing Framework for Naltrexone in Relapse Prevention (Opioid Dependence)

Prescribing Framework for Naltrexone in Relapse Prevention (Opioid Dependence) Hull & East Riding Prescribing Committee Prescribing Framework for Naltrexone in Relapse Prevention (Opioid Dependence) Patients Name: Unit Number: Patients Address:.. G.P s Name:.. Communication We agree

More information

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical

More information

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007 Alberta Alcohol and Drug Abuse Commission POSITION ON ADDICTION AND MENTAL HEALTH POSITION The Alberta Alcohol and Drug Abuse Commission (AADAC) recognizes that among clients with addiction problems, there

More information

Dr Alistair Dunn. General Practitioner Whangarei

Dr Alistair Dunn. General Practitioner Whangarei Dr Alistair Dunn General Practitioner Whangarei 1982 Temgesic = Buprenorphine Sublingual opiate analgesic 0.2 mg Popular drug of abuse 1991 Temgesic NX = Bup & Nalxone Nalxone added to deter abuse 1999

More information

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION Naltrexone is used as part of a comprehensive programme of treatment against alcoholism to reduce the

More information

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Substitution Therapy for Opioid Use Disorder The Role of Suboxone Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM

More information

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers

More information

Essential Shared Care Agreement Naltrexone

Essential Shared Care Agreement Naltrexone In partnership with as part of Please complete the following details: Patient s name, address, date of birth Consultant s contact details (p.3) And send One copy to: 1. The patient s GP 2. Put one copy

More information

Bipolar Disorder Clinical Practice Guideline Summary for Primary Care

Bipolar Disorder Clinical Practice Guideline Summary for Primary Care Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,

More information

Up Pain, Down Pain, Good Brain, Bad Brain Simplifying the Complexity of Chronic Pain. Michael Coupland, RPsych CRC

Up Pain, Down Pain, Good Brain, Bad Brain Simplifying the Complexity of Chronic Pain. Michael Coupland, RPsych CRC Up Pain, Down Pain, Good Brain, Bad Brain Simplifying the Complexity of Chronic Pain Michael Coupland, RPsych CRC Putting the pieces together Learning Objectives The attendee will gain an understanding

More information

Management of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013

Management of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013 Management of high risk MMT patients Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013 CFPC CoI Templates: Slide 1 Faculty Disclosure Faculty: Meldon Kahan Relationships with commercial

More information

Buprenorphine as a Treatment Option for Opioid Use Disorder

Buprenorphine as a Treatment Option for Opioid Use Disorder Buprenorphine as a Treatment Option for Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry Brigham and Women s Hospital

More information

Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue

Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue Scope Pharmacology of Opioids Equivalence Dependence and Withdrawal Methadone Maintenance (OST) 3 Opioid

More information

C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS

C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS 1.0 Introduction Medications are used in the treatment of drug, alcohol and nicotine dependence to manage

More information

We acknowledge the traditional custodians of the land on which we meet today and pay respect to Elders past, present and emerging.

We acknowledge the traditional custodians of the land on which we meet today and pay respect to Elders past, present and emerging. We acknowledge the traditional custodians of the land on which we meet today and pay respect to Elders past, present and emerging. We also extend that respect to other Aboriginal and/or Torres Strait Islanders

More information

The future of pharmacological treatment.

The future of pharmacological treatment. The future of pharmacological treatment. Anne Lingford-Hughes Professor of Addiction Biology, Imperial College. Hon Consultant CNWL NHS Foundation Trust. What substances and when? What Nicotine Alcohol

More information

Challenges in Prison Dentistry. Dr Ruth Gray National Association of Prison Dentistry UK

Challenges in Prison Dentistry. Dr Ruth Gray National Association of Prison Dentistry UK Challenges in Prison Dentistry Dr Ruth Gray ruth.gray@setrust.hscni.net National Association of Prison Dentistry UK Demand Greater Than Supply Prison Setting Hydebank Wood College, Belfast Young Offenders-

More information

Prescribing Framework for Naltrexone in Alcohol Relapse Prevention

Prescribing Framework for Naltrexone in Alcohol Relapse Prevention Prescribing Framework for Naltrexone in Alcohol Relapse Prevention Patients Name:.. NHS Number: Patients Address:... (Use addressograph sticker) GP s Name:... Communication We agree to treat this patient

More information

NHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification

NHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification NHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) Rationale General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification Aims It is the responsibility of general practitioners

More information

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine Natural derivatives of opium poppy - Opium - Morphine - Codeine Opioid Agonists Semi synthetics: Derived from chemicals in opium -Diacetylmorphine Heroin - Hydromorphone Synthetics - Oxycodone Propoxyphene

More information

New service available for VoY Ryedale practice patients

New service available for VoY Ryedale practice patients New service available for VoY Ryedale practice patients Scarborough Pain (Enablement) Service For some time, NHS Scarborough & Ryedale CCG and York Teaching Hospital Foundation Trust have had a service

More information

Dementia Care Pathway

Dementia Care Pathway Document level: West Locality Code: CC41 Issue number: 1 Dementia Care Pathway Lead executive Authors details Type of document Target audience Document purpose Medical Director Dr Anushta Sivananthan Dr

More information

TOOL 1: QUESTIONS BY ASAM DIMENSIONS

TOOL 1: QUESTIONS BY ASAM DIMENSIONS TOOL 1: QUESTIONS BY ASAM DIMENSIONS The following tool highlights specific questions that should be asked of the patient for each ASAM dimension. Name Date of Birth Date of Interview Address Referred

More information

Conduct Disorder in Children and Young People (CYP 5-18 years of age) RISPERIDONE Effective Shared Care Agreement (ESCA)

Conduct Disorder in Children and Young People (CYP 5-18 years of age) RISPERIDONE Effective Shared Care Agreement (ESCA) E102 Conduct Disorder in Children and Young People (CYP 5-18 years of age) RISPERIDONE Effective Shared Care Agreement (ESCA) Patient details Name: Date of birth: NHS number: Contact details Specialist:

More information

1.4 The CADAS teams do not provide a service for residents of Bournemouth or Poole.

1.4 The CADAS teams do not provide a service for residents of Bournemouth or Poole. Pan Dorset Prescribing Protocol 1- Introduction 1.1 This policy provides guidance in relation to the Community Alcohol and Drug Service (CADAS). The service offers pharmacological interventions alongside

More information

Medication Assisted Treatment. Nicole Gastala, MD

Medication Assisted Treatment. Nicole Gastala, MD Medication Assisted Treatment Nicole Gastala, MD Objectives Training Goals: To enhance the understanding of the participants in use of medication assisted therapy To increase the knowledge of participants

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2008 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Concurrent Disorders

Concurrent Disorders Concurrent Disorders Dr. Christy Sutherland MD CCFP dipabam Medical Director, PHS Community Services Methadone/Buprenorphine 101 Workshop April 1, 2017 Overview Introduction Epidemiology Treatment Principles

More information

Substance misuse: dual diagnosis, taking steps to improve care

Substance misuse: dual diagnosis, taking steps to improve care Substance misuse: dual diagnosis, taking steps to improve care Presented by: Kerry Trinder, Head of Services for the Black Country Marcin Parakoyi MRCPsych, Consultant Psychiatrist Date: 20 th September

More information

Prescription Opioid Addiction

Prescription Opioid Addiction CSAM-SCAM Fundamentals Prescription Opioid Addiction Presentation provided by Meldon Kahan, MD Family & Community Medicine University of Toronto Conflict of interest statement I received funds from Rickett

More information

Introduction: Purpose:

Introduction: Purpose: Introduction: This Recovery Outcomes Web tool is a validated tool which has been developed by the Scottish Government in partnership with a broad range of stakeholders, including Alcohol & Drug Partnerships

More information

IDDT Fidelity Action Planning Guidelines

IDDT Fidelity Action Planning Guidelines 1a. Multidisciplinary Team IDDT Fidelity Action Planning Guidelines Definition: All clients targeted for IDDT receive care from a multidisciplinary team. A multi-disciplinary team consists of, in addition

More information

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015 Analgesia for Patients with Substance Abuse Disorders Lisa Jennings CN November 2015 Definitions n Addiction: A pattern of drug use characterised by aberrant drug-taking behaviours & the compulsive use

More information

Template Control Page. Substance Misuse Newham Template Guide. Substance Misuse Newham. Date September 2015 DOCUMENT MANAGEMENT REVISION HISTORY

Template Control Page. Substance Misuse Newham Template Guide. Substance Misuse Newham. Date September 2015 DOCUMENT MANAGEMENT REVISION HISTORY Template Control Page Substance Misuse Newham Template Guide Title Substance Misuse Newham Author CEG Status Active Date September 2015 DOCUMENT MANAGEMENT REVISION HISTORY Version Date Summary of Changes

More information

GOALS AND OBJECTIVES

GOALS AND OBJECTIVES SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES

More information

Successful discharges from opiate substitution therapy dose reduction to zero

Successful discharges from opiate substitution therapy dose reduction to zero Successful discharges from opiate substitution therapy dose reduction to zero Robert Cohen Consultant Addiction Psychiatrist CGL Luton 9 November 017 Introduction The UK Drug Strategy (017) aims to achieve

More information

Substance Use Disorders in Primary Care

Substance Use Disorders in Primary Care Substance Use Disorders in Primary Care Jin Hee Yoon-Hudman, MD Assistant Vice President, Medical Director, Behavioral Health Healthfirst Fall Symposium Prevention as a Priority in Value-Based Healthcare,

More information

Opioid Overdose Epidemic A Crises and Opportunity

Opioid Overdose Epidemic A Crises and Opportunity Opioid Overdose Epidemic A Crises and Opportunity Samuel M. Silverman MD, FAPA, DFASAM Assistant Clinical Professor, UConn Medical School Director, Medical Education Rushford, A Hartford HealthCare Partner

More information

Depression & Alcohol

Depression & Alcohol Depression & Alcohol Black Dog Institute Mission: To advance the understanding and management of the mood disorders through Research Clinical Services Community Support Education Community Support Clinical

More information

BROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes.

BROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes. 13. Substance Misuse Introduction Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes. The term substance misuse often refers to illegal drugs, but, some

More information

PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS

PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS PALLIATIVE CARE PRESCRIBING FOR PATIENTS WHO ARE SUBSTANCE MISUSERS Background information Substance misusers who develop palliative care needs are likely to have psychological, social and existential

More information

Pharmacotherapy for Substance Use Disorders

Pharmacotherapy for Substance Use Disorders Pharmacotherapy for Substance Use Disorders Vanessa de la Cruz, MD Chief of Psychiatry Mental Health and Substance Abuse Services Santa Cruz County Health Services Agency 1400 Emeline Avenue Santa Cruz,

More information

THERAPEUTIC CONSIDERATIONS OF PSYCHOPHARMACOLOGY OF OPIATE USE DISORDER. Presenter: Linda Shaffer MA, Ed.S., LCAS, MAC

THERAPEUTIC CONSIDERATIONS OF PSYCHOPHARMACOLOGY OF OPIATE USE DISORDER. Presenter: Linda Shaffer MA, Ed.S., LCAS, MAC THERAPEUTIC CONSIDERATIONS OF PSYCHOPHARMACOLOGY OF OPIATE USE DISORDER Presenter: Linda Shaffer MA, Ed.S., LCAS, MAC LEARNING OBJECTIVES Know who to put on agonist (buprenorphine) therapy? Client contracts

More information

Models of good practice in drug treatment in Europe. Project group

Models of good practice in drug treatment in Europe. Project group Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008

More information

Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018

Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018 Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use Chad Morris, PhD March 7, 2018 2018 BHWP Behavioral Causes of Death in U.S. 2018 BHWP 2018 BHWP Health Disparities Population Behavioral

More information

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs

More information

Module Two: Pharmacotherapies for Opioid Substitution Treatment

Module Two: Pharmacotherapies for Opioid Substitution Treatment Module Two: Pharmacotherapies for Opioid Substitution Treatment Neurobiology of Addiction Pharmacology of Opioids Methadone Buprenorphine Pharmacokinetics of Methadone & Buprenorphine Opioid effects Intoxication

More information

McLean Ambulatory Treatment Center Adult Partial Hospital and Residential Program for Alcohol and Drug Abuse 115 Mill Street Belmont, MA 02478

McLean Ambulatory Treatment Center Adult Partial Hospital and Residential Program for Alcohol and Drug Abuse 115 Mill Street Belmont, MA 02478 Alcohol and Drug Abuse Partial Hospital Program Referral Packet McLean Ambulatory Treatment Center Program Description Staffed by highly experienced psychiatrists, psychologists, social workers, nurses

More information

IntNSA Webinar Series

IntNSA Webinar Series BUPRENORPHINE CLINIC: A MULTIDISCIPLINARY MODEL FOR OPIOID MAINTENANCE THERAPY Stephen Strobbe, PhD, RN, NP, PMHCNS-BC, CARN-AP Monday, June 4, 2012 IntNSA Webinar Series Funding for this webinar was made

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit

More information

What is the Role of Addiction Medicine in Chronic Pain Management? Douglas W. Teller, M.D.

What is the Role of Addiction Medicine in Chronic Pain Management? Douglas W. Teller, M.D. What is the Role of Addiction Medicine in Chronic Pain Management? Douglas W. Teller, M.D. (Doug.Teller@khnetwork.org) The Paralytic at Capernaum Luke 5:18-26 v. 20 And when He saw their faith, He said

More information

Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Abbreviated Version

Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Abbreviated Version Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Abbreviated Version Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of

More information

Wear Recovery. Sunderland Integrated Drug & Alcohol Services

Wear Recovery. Sunderland Integrated Drug & Alcohol Services Wear Recovery Sunderland Integrated Drug & Alcohol Services Partnership Presentation Introduction to individual organisations NTW DISC Changing Lives Introduction to the Model Pathway Phasing and Layering

More information

Substance Misuse in Older People

Substance Misuse in Older People Substance Misuse in Older People Dr Tony Rao Consultant Old Age Psychiatrist, SLAM NHS Foundation Trust Visiting Researcher, Institute of Psychiatry, Neurology and Neuroscience Chair of Substance Misuse

More information

Table to Demonstrate a method of working through Triggered CAPs.

Table to Demonstrate a method of working through Triggered CAPs. CAP Problem Goals Triggers Guidelines Physical Activities increase hours of exercises Reports less than 2 hours Personal choice Promotion and physical activity activity in last 3 days Instrumental Activities

More information

The forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre

The forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre The forgotten group: a new HIV outbreak amongst people who inject drugs Patricia Anderson Lead CNS BBV Brownlee Centre No conflicts to declare Potted History 1981 Modern wave of drug misuse Glasgow soared

More information

Australia s ageing population: Implications for alcohol and other drug prevention and treatment services.

Australia s ageing population: Implications for alcohol and other drug prevention and treatment services. Australia s ageing population: Implications for alcohol and other drug prevention and treatment services. Paul Haber MBBS BMedSc MD FRACP FAChAM Senior Staff Specialist, Drug Health Services, Royal Prince

More information

Managing Opiate prescribing and dispensing. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

Managing Opiate prescribing and dispensing. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead Managing Opiate prescribing and dispensing By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead PLAN OF PRESENTATION Impact of addiction on society and journey into addiction Medical

More information

John Murphy DO, MS Lynx Healthcare

John Murphy DO, MS Lynx Healthcare Addiction to Pain Medication and Treatment John Murphy DO, MS Lynx Healthcare No Disclosures Objectives 1 Understand basic neurobiology and learning theory around opioid addiction 2 Identify aberrant behavior

More information

UNHEALTHY ALCOHOL USE SCREENING and FOLLOW-UP (ASF) HEDIS (Administrative)

UNHEALTHY ALCOHOL USE SCREENING and FOLLOW-UP (ASF) HEDIS (Administrative) UNHEALTHY ALCOHOL USE SCREENING and FOLLOW-UP (ASF) APPLICATIONS OBJECTIVE Purpose of Measure: ELIGIBLE POPULATION Which members are included? STANDARD OF CARE NCQA ACCEPTED CODES HEDIS (Administrative)

More information

A healthy lifestyles approach to co-existing mental health and substance use problems Amanda Baker PhD

A healthy lifestyles approach to co-existing mental health and substance use problems Amanda Baker PhD A healthy lifestyles approach to co-existing mental health and substance use problems Amanda Baker PhD Outline 2 Context Early studies addressing co-existing problems Depression and AOD use Smoking in

More information

Assessment and Treatment of Repeat Impaired Drivers

Assessment and Treatment of Repeat Impaired Drivers Assessment and Treatment of Repeat Impaired Drivers Cross Agency Presentation to Addiction Leadership Day Wellington 19 April 2012 Overview of Panel Discussion Implementing Alcohol Interlock Devices Kathryn

More information

Substance use and misuse

Substance use and misuse An open learning programme for pharmacists and pharmacy technicians Substance use and misuse Educational solutions for the NHS pharmacy workforce DLP 160 Contents iii About CPPE open learning programmes

More information

Substance Misuse - Improving Services and Supporting Offenders. Nino Maddalena CJ lead Alcohol & Drugs, Public Health England

Substance Misuse - Improving Services and Supporting Offenders. Nino Maddalena CJ lead Alcohol & Drugs, Public Health England Substance Misuse - Improving Services and Supporting Offenders Nino Maddalena CJ lead Alcohol & Drugs, Public Health England Overview Recovery agenda looking at the drug and alcohol problems of the offender

More information

PRISONER PROGRAMMES. November 2013

PRISONER PROGRAMMES. November 2013 PRISONER PROGRAMMES November 2013 CONTENTS CARE - Controlling Anger and Regulating Emotions CONSTRUCTS - A General Offending Programme Making Changes Moving Forward Rolling Sex Offender Treatment Programme

More information

Evaluation of an Enhanced Drug Treatment Court Santa Barbara County, California,USA

Evaluation of an Enhanced Drug Treatment Court Santa Barbara County, California,USA Evaluation of an Enhanced Drug Treatment Court Santa Barbara County, California,USA Merith Cosden June 19, 212 Drug Court Enhancements Address clients trauma Serve adults with co-occurring disorders Implement

More information

Alcoholism has been demonstrated to have a genetic component, especially among men.

Alcoholism has been demonstrated to have a genetic component, especially among men. Causes and Treatment of Substance-Related Disorders (Chapter 10) Familial and Genetic Influences Alcoholism has been demonstrated to have a genetic component, especially among men. Seems to be a common

More information

The contribution of applied psychologists to recovery oriented substance misuse treatment systems

The contribution of applied psychologists to recovery oriented substance misuse treatment systems The contribution of applied psychologists to recovery oriented substance misuse treatment systems Dr. Christopher Whiteley Consultant Clinical Psychologist South London & Maudlsey NHS Foundation Trust

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Welcome to the Opioid Overdose Prevention Project

Welcome to the Opioid Overdose Prevention Project Welcome to the Opioid Overdose Prevention Project Narcan Training TODAY S OBJECTIVES Define drug addiction Identify symptoms of addiction Treatment options including support for family members How to recognize

More information

SHARED CARE MANUAL GUIDELINES FOR SHARED CARE TREATMENT OF OPIATE DEPENDENCY

SHARED CARE MANUAL GUIDELINES FOR SHARED CARE TREATMENT OF OPIATE DEPENDENCY SHARED CARE MANUAL GUIDELINES FOR SHARED CARE TREATMENT OF OPIATE DEPENDENCY Compiled by Addaction in Consultation with NHS North Somerset A North Somerset Drug Action Team Partnership Initiative Partnership

More information

Managing drug misuse in pregnancy and beyond

Managing drug misuse in pregnancy and beyond Managing drug misuse in pregnancy and beyond Dr Emily Finch Clinical Director Addictions Clinical Academic Group South London and Maudsley NHS Foundation Trust Rachael Evans Policy and Research Officer

More information

ROSC & MAT II: Opioid Treatment Services

ROSC & MAT II: Opioid Treatment Services ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify

More information

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home

More information

Module II Opioids 101 Opiate Opioid

Module II Opioids 101 Opiate Opioid BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module II Opioids 101 Module II Goals of the Module This module reviews the following:! Opioid addiction and the brain!

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging. David W. Oslin, MD University of Pennsylvania Philadelphia VAMC Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging. Dr. Oslin is a consultant to the Hazelden Betty

More information

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview.

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond David Anisman, MD Medical Director, Farmington Health Center (Primary Care) Associate Medical Director, Community

More information

Drug Misuse and Dependence Guidelines on Clinical Management

Drug Misuse and Dependence Guidelines on Clinical Management Department of Health Scottish Office Department of Health Welsh Office Department of Health and Social Services, Northern Ireland Drug Misuse and Dependence Guidelines on Clinical Management An Executive

More information

Mood Disorders and Addictions: A shared biology?

Mood Disorders and Addictions: A shared biology? Mood Disorders and Addictions: A shared biology? Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Disclosures No relevant disclosures: No paid

More information

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS Ending Addiction Changes Everything RECOMMENDATIONS FOR HEALTH CARE PROVIDERS CRITICAL ADDICTION PREVENTION, TREATMENT AND MANAGEMENT SERVICES TO INCLUDE IN ROUTINE HEALTH CARE PRACTICE JULY 2013 In the

More information

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory Opioids: Use, Abuse and Cause of Death Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory jharmon@occl.ocgov.com Opioid: Any psychoactive chemical that resembles morphine

More information

Guidance For The Use Of Naltrexone In The Maintenance Of Abstinence in Formerly Opioid Dependent Adults By Clinicians Working Within NHS Grampian

Guidance For The Use Of Naltrexone In The Maintenance Of Abstinence in Formerly Opioid Dependent Adults By Clinicians Working Within NHS Grampian Title: Identifier: Guidance For The Use Of Naltrexone In The Maintenance Of Abstinence in Formerly Opioid Dependent Adults By Clinicians Working Within NHS Grampian NHSG/Guide/NHSG_NaltexMA_885 Replaces:

More information